Project Number ARUK-TVPG2018-002 Agency/Funding Organization Alzheimer's Research UK Funding Year 2017 View Full Project Details for Identifying the molecular target of the drug trazodone responsible for its neuroprotective effects Research Categorization Primary Disease / Condition Alzheimer's Disease Frontotemporal Dementia CADRO Category C. Translational Research and Clinical Interventions 2. Identification and Validation of Novel Targets Researcher and Organization Principal Investigator Mark Halliday Principal Investigator First Name Mark Principal Investigator Last Name Halliday Awardee Organization UNIVERSITY OF CAMBRIDGE Contact PI Country United Kingdom Project Detail FY Overall Cost $49,209 Funding Organization Agency/Funding Organization Alzheimer's Research UK Funding Organization Country United Kingdom
